Respirable antisense oligonucleotides as novel therapeutic agents for asthma and other pulmonary diseases

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.9, 1997-09, pp. : 1149-1156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Oligonucleotides As Therapeutic Agents

By Alama A. Barbieri F. Cagnoli M. Schettini G.

Pharmacological Research, Vol. 36, Iss. 3, 1997-09 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite

Clinical Potential of Respirable Antisense Oligonucleotides (RASONs) in Asthma

By Ball H.A. Sandrasagra A. Tang L. Van Scott M. Wild J. Nyce J.W.

American Journal of PharmacoGenomics, Vol. 3, Iss. 2, 2003-01 ,pp. : 97-106

Adis International

Access to resources Recommend Favorite

Clinical trials of a new class of therapeutic agents: antisense oligonucleotides

By Galderisi U. Cipollaro M. Cascino A.

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. : 69-79

Informa Healthcare

Access to resources Recommend Favorite

Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases

By Henry S.P. Danis R.P.

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 2, 2001-02 ,pp. : 277-291

Informa Healthcare

Access to resources Recommend Favorite

Modification of Alternative Splicing by Antisense Oligonucleotides as a Potential Chemotherapy for Cancer and Other Diseases

Current Cancer Drug Targets, Vol. 1, Iss. 3, 2001-11 ,pp. : 211-230

Bentham Science Publishers

Access to resources Recommend Favorite